Kinnevik Ab (Publ) Recursion Pharmaceuticals, Inc. Transaction History
Kinnevik Ab (Publ)
- $89.3 Million
- Q2 2024
A detailed history of Kinnevik Ab (Publ) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Kinnevik Ab (Publ) holds 11,905,668 shares of RXRX stock, worth $83.1 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
11,905,668
Previous 10,405,668
14.42%
Holding current value
$83.1 Million
Previous $104 Million
13.93%
% of portfolio
100.0%
Previous 100.0%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
285Shares Held
236MCall Options Held
972KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl28.1MShares$196 Million1.92% of portfolio
-
Baillie Gifford & CO26.6MShares$186 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$121 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$107 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.26B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...